|
Volumn 289, Issue 5478, 2000, Pages 409-411
|
Imaging: A molecular map for neurodegeneration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALZHEIMER DISEASE;
DIAGNOSTIC IMAGING;
DISEASE COURSE;
DISEASE MARKER;
HUMAN;
NERVE DEGENERATION;
PARKINSON DISEASE;
PATHOGENESIS;
PRIORITY JOURNAL;
REVIEW;
ARTICLE;
BRAIN;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CORPUS STRIATUM;
DEGENERATIVE DISEASE;
GENETIC PREDISPOSITION;
GENETICS;
INSTRUMENTATION;
METABOLISM;
PATHOLOGY;
SCINTISCANNING;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SUBSTANTIA NIGRA;
BIOLOGICAL MARKER;
DIAGNOSTIC AGENT;
DOPAMINE;
NEUROTRANSMITTER RECEPTOR;
RADIOPHARMACEUTICAL AGENT;
BIOLOGICAL MARKERS;
BRAIN;
CORPUS STRIATUM;
DISEASE PROGRESSION;
DOPAMINE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
NERVE DEGENERATION;
NEURODEGENERATIVE DISEASES;
PARKINSON DISEASE;
RADIOPHARMACEUTICALS;
RECEPTORS, NEUROTRANSMITTER;
SUBSTANTIA NIGRA;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 0034698296
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.289.5478.409 Document Type: Review |
Times cited : (20)
|
References (23)
|